Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2004-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328dafa2b3dc9be607f20849476cb830 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a24443e7f4502fe3d1581fd3acd3df32 |
publicationDate |
2005-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005043382-A1 |
titleOfInvention |
Novel combination of a factor Xa inhibitor and clopidogrel |
abstract |
The present application describes methods of using a combination of 1-(3′-aminobenzisoxazol-5′-yl)-3-trifluoromethyl-5-[[4-[(2′-dimethylaminomethyl)imidazol-1′-yl]-2-fluorophenyl]aminocarbonyl]pyrazole-hydrochloric acid salt, a factor Xa inhibitor, and Clopidogrel as anticoagulant agents for treatment of thromboembolic disorders and pharmaceutical compositions containing the same. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022501320-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3766493-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7150976-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020045940-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008134600-A1 |
priorityDate |
2002-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |